Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dana-Farber's team of breast cancer experts is dedicated to improving the care of male breast cancer. Our physician scientists are engaged in multiple research studies to better understand the needs of men with breast cancer.
In addition, we offer our breast cancer patients access to more than 40 breast cancer clinical trials at a time, many of which are available to men.
Our team has published many findings related to breast cancer in men, including:
Management of Male Breast Cancer: ASCO Guideline: These are recommendations for the treatment of male breast cancer put together by a panel of experts, including researchers at Dana-Farber
Prognostic significance of tumor subtypes in male breast cancer: a population-based study: This study was the first to describe the prognosis of each type of breast cancer that occurs
in men. It illustrates that the different types of breast cancer in men have very different prognoses.
Locoregional treatment and overall survival of men with T1a, b, cN0M0 breast cancer: A population-based study: The current standard surgery for most men with breast cancer is a total
mastectomy. However, this study showed that in men with small breast cancers, lumpectomy (which is a smaller surgery) can be an effective alternative to total mastectomy.
Prognostic factors in male breast cancer: a population-based study: This study evaluated several factors associated with prognosis in men with breast cancer in the modern era.
Overall Survival of Men and Women with Breast Cancer According to Tumor Subtype: A Population-based Study: This study evaluated overall survival of men compared with women with breast
cancer. The study compared survival of men and women by each specific type of breast cancer, allowing for a more appropriate comparison.
Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer: A National Cancer Database study: In women with certain types of
breast cancer, chemotherapy before surgery is often recommended. This study was the first to evaluate the efficacy of chemotherapy before surgery for each type of breast cancer in men and compared the results with the efficacy we see in women.
The prognostic significance of metastatic pattern in stage IV male breast cancer at initial diagnosis: a population-based study: This study evaluated the prognosis of men with metastatic
breast cancer, comparing different sites of metastases.
New Patient Appointments
Faces of Male Breast Cancer Awareness | Male Breast Cancer Coalition, January 2018Jose Pablo Leone, MD, discusses the results of one of his research studies presented at San Antonio Breast Cancer Symposium with Michael Singer from the Male Breast Cancer Coalition.